Currently Lonza supply under agreement. Swiss company, quite large, lots of resources. That is one option to pursue.
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-251
-
- There are more pages in this discussion • 597 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.025(2.22%) |
Mkt cap ! $1.307B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.17 | $1.13 | $1.105M | 962.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 17218 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 5431 | 5 |
View Market Depth
| Last trade - 10.48am 30/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |